122 related articles for article (PubMed ID: 10704935)
1. Stimulation of vitamin A(1) acid signaling by the HIV protease inhibitor indinavir.
Lenhard JM; Weiel JE; Paulik MA; Furfine ES
Biochem Pharmacol; 2000 May; 59(9):1063-8. PubMed ID: 10704935
[TBL] [Abstract][Full Text] [Related]
2. HIV protease inhibitors block adipogenesis and increase lipolysis in vitro.
Lenhard JM; Furfine ES; Jain RG; Ittoop O; Orband-Miller LA; Blanchard SG; Paulik MA; Weiel JE
Antiviral Res; 2000 Aug; 47(2):121-9. PubMed ID: 10996400
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells.
Ikezoe T; Daar ES; Hisatake J; Taguchi H; Koeffler HP
Blood; 2000 Nov; 96(10):3553-9. PubMed ID: 11071654
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
Schütt M; Zhou J; Meier M; Klein HH
J Endocrinol; 2004 Dec; 183(3):445-54. PubMed ID: 15590971
[TBL] [Abstract][Full Text] [Related]
5. HIV protease inhibitors stimulate hepatic triglyceride synthesis.
Lenhard JM; Croom DK; Weiel JE; Winegar DA
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2625-9. PubMed ID: 11116063
[TBL] [Abstract][Full Text] [Related]
6. Select HIV protease inhibitors alter bone and fat metabolism ex vivo.
Jain RG; Lenhard JM
J Biol Chem; 2002 May; 277(22):19247-50. PubMed ID: 11937496
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 protease inhibitors. A review for clinicians.
Deeks SG; Smith M; Holodniy M; Kahn JO
JAMA; 1997 Jan; 277(2):145-53. PubMed ID: 8990341
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir.
Grigorian A; Hurford R; Chao Y; Patrick C; Langford TD
BMC Neurosci; 2008 Feb; 9():27. PubMed ID: 18302767
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antiadipogenic effects of HIV type 1 protease inhibitors with tumor necrosis factor alpha: suppression of extracellular insulin action mediated by extracellular matrix-degrading proteases.
Mondal D; Larussa VF; Agrawal KC
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1569-84. PubMed ID: 11779345
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation.
Vernochet C; Azoulay S; Duval D; Guedj R; Ailhaud G; Dani C
AIDS; 2003 Oct; 17(15):2177-80. PubMed ID: 14523274
[TBL] [Abstract][Full Text] [Related]
11. Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors.
Jones SP; Janneh O; Back DJ; Pirmohamed M
Antivir Ther; 2005; 10(2):207-13. PubMed ID: 15865214
[TBL] [Abstract][Full Text] [Related]
12. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.
Périard D; Telenti A; Sudre P; Cheseaux JJ; Halfon P; Reymond MJ; Marcovina SM; Glauser MP; Nicod P; Darioli R; Mooser V
Circulation; 1999 Aug; 100(7):700-5. PubMed ID: 10449690
[TBL] [Abstract][Full Text] [Related]
13. HIV-protease inhibitors alter retinoic acid synthesis.
Toma E; Devost D; Chow Lan N; Bhat PV
AIDS; 2001 Oct; 15(15):1979-84. PubMed ID: 11600826
[TBL] [Abstract][Full Text] [Related]
14. HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/RXR heterodimer.
Wentworth JM; Burris TP; Chatterjee VK
J Endocrinol; 2000 Feb; 164(2):R7-R10. PubMed ID: 10657860
[TBL] [Abstract][Full Text] [Related]
15. Dietary fat alters HIV protease inhibitor-induced metabolic changes in mice.
Lenhard JM; Croom DK; Weiel JE; Spaltenstein A; Reynolds DJ; Furfine ES
J Nutr; 2000 Sep; 130(9):2361-6. PubMed ID: 10958836
[TBL] [Abstract][Full Text] [Related]
16. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
17. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
[TBL] [Abstract][Full Text] [Related]
18. Indinavir and nelfinavir inhibit proximal insulin receptor signaling and salicylate abrogates inhibition: potential role of the NFkappa B pathway.
Ismail WI; King JA; Anwar K; Pillay TS
J Cell Biochem; 2013 Aug; 114(8):1729-37. PubMed ID: 23386514
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid ameliorates photoaged skin through RAR‑mediated pathway in mice.
Li Z; Niu X; Xiao S; Ma H
Mol Med Rep; 2017 Nov; 16(5):6240-6247. PubMed ID: 28849147
[TBL] [Abstract][Full Text] [Related]
20. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
